financetom
Business
financetom
/
Business
/
COLUMN-Dollar strength reminds Wall Street 'US exceptionalism' isn't isolationism: McGeever
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
COLUMN-Dollar strength reminds Wall Street 'US exceptionalism' isn't isolationism: McGeever
Jan 14, 2025 7:26 AM

ORLANDO, Florida, Jan 14 (Reuters) - While "U.S.

exceptionalism" has undoubtedly helped drive Wall Street's

record-busting returns in recent years, it should not be

confused with isolationism.

The fourth-quarter U.S. earnings season that gets underway

in earnest this week is a reminder that American firms -

magnificent as some may be - still operate in a global

marketplace. Weak economies and lackluster demand abroad,

combined with a robust dollar, could erode American corporate

profitability, calling into question whether the U.S. is so

exceptional after all.

With the dollar appreciating broadly and rapidly, exchange

rates will soon bite into corporate profitability. The question

is how deep.

Analysts at Apollo Global Management note that more than 41%

of S&P 500 firms' revenues come from abroad. That's the highest

since 2013 and not far behind the record high of 43.3% in 2011.

This leaves these firms vulnerable on two levels. First,

sub-par growth in many key economies and trading partners such

as China, Canada and Europe should, all else being equal, cause

demand for U.S. goods to weaken. And second, revenues accrued

abroad will now be worth significantly less in dollar terms than

they would have a year ago.

The dollar is on a tear. It has risen 10% since late

September and is up 7% year-over-year. It is now the strongest

it has been in more than two years against a basket of G10

currencies, notching multi-year highs against sterling and the

Canadian dollar.

There is little sign of this trend reversing any time soon,

as resilient U.S. growth and sticky inflation lift Treasury

yields and force investors to radically rethink their 2025 Fed

outlook. Bank of America economists no longer expect any rate

cuts this year and others are even suggesting the central bank's

next move may be a hike. In turn, Goldman Sachs analysts on

Friday raised their "stronger for longer" dollar forecasts.

DOLLAR IDIOSYNCRASY

Although much of the classic economic play-book has been

ripped up since the pandemic, theory still suggests a 10%

year-on-year increase in the dollar should reduce S&P 500

earnings by around 3%, according to BofA. Currently, estimates

point to 9.5% growth in aggregate earnings per share for the

fourth quarter, and 14% for calendar years 2025, according to

LSEG I/B/E/S.

But fourth-quarter revenue growth is only estimated at 4.1%,

a relatively slow pace in part due to the exchange rate.

Revenue "beats" tend to decline in periods of dollar

strength compared with periods of dollar weakness, Goldman Sachs

equity analysts say. So we can reasonably expect that the share

of firms beating consensus sales forecasts this quarter will be

lower than the 42% that did so in the previous period, when the

dollar's year-on-year rise was only 2%.

But even though dollar strength is likely to feature in many

CEO and CFO calls this earnings season, its impact on U.S.

earnings may be more "idiosyncratic" than widespread, according

to Morgan Stanley's Mike Wilson.

He has noted that the stocks of companies with "relatively

low foreign sales exposure and low sensitivity to a stronger

dollar from an EPS growth standpoint" have begun to outperform

since the dollar started to strengthen in October.

He characterizes "low" foreign exposure as companies that

derive less than 15% of their revenues from abroad, giving them

"minimal" sensitivity to the dollar's exchange rate. Some of the

big names in this camp include United Healthcare, T-Mobile and

Home Depot ( HD ), while some large caps that derive more than 15% of

their revenues from overseas include PepsiCo ( PEP ), IBM ( IBM ) and Oracle.

The dollar's strength is not yet at a level that truly

threatens corporate America's competitiveness and profitability.

But if it persists, this earnings season could be a taste of

what's to come.

(The opinions expressed here are those of the author, a

columnist for Reuters.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sylvamo Insider Sold Shares Worth $1,384,225, According to a Recent SEC Filing
Sylvamo Insider Sold Shares Worth $1,384,225, According to a Recent SEC Filing
Mar 18, 2025
11:32 AM EDT, 03/18/2025 (MT Newswires) -- Jean-Michel Ribieras, Director, Chairman and CEO, on March 17, 2025, sold 21,250 shares in Sylvamo ( SLVM ) for $1,384,225. Following the Form 4 filing with the SEC, Ribieras has control over a total of 131,894 common shares of the company, with 131,894 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1856485/000156218025002493/xslF345X05/primarydocument.xml Price: 65.87, Change: +0.25,...
German premium carmakers weigh price, production shifts to soften tariff blow
German premium carmakers weigh price, production shifts to soften tariff blow
Mar 18, 2025
* Audi, BMW, Mercedes-Benz exposed to U.S. import tariffs * Audi considering passing some of tariff costs on - CFO * Mercedes: decision on U.S. production depends on competition * Mercedes: Could consider importing cars from South Africa (Adds Mercedes-Benz comments on tariffs, recasts with context) By Alexander Hübner, Christoph Steitz and Victoria Waldersee INGOLSTADT/BERLIN, Germany, March 18 (Reuters) -...
Why Aditxt (ADTX) Stock Is Skyrocketing
Why Aditxt (ADTX) Stock Is Skyrocketing
Mar 18, 2025
Aditxt Inc ( ADTX ) shares are trading higher by 96.5% to $8.58 during Tuesday’s session after the company announced it submitted an application for four new federal funding opportunities. What To Know: Aditxt ( ADTX ) shares are trading higher after its subsidiary, Adivir, and its acquisition target, Appili Therapeutics, announced applications for up to $117.5 million in U.S....
Update: G2 Goldfields Up 3% as It Reports a
Update: G2 Goldfields Up 3% as It Reports a "Significant" Gold Discovery Near Its OKO Project in Guyana
Mar 18, 2025
11:34 AM EDT, 03/18/2025 (MT Newswires) -- (Updates shares.) G2 Goldfields ( GUYGF ) on Tuesday reported a significant gold discovery several miles north of the company's existing OKO gold project in Guyana. Assays include 24 meters grading 2 grams per tonne (g/t) gold, including 9.3 meters grading 2.8 g/t gold. The company noted the discovery lies within properties in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved